Show an ad over header. AMP

I am the FIRST!!!

The Fed is back in focus amid Congress' stimulus impasse

Even though the Fed's policymaking committee has no meeting scheduled until mid-September, more attention is turning to the central bank as inflation has begun to pick up and Congress left town without delivering a new round of fiscal stimulus.

Why it matters: Since its unprecedented intervention into financial markets in March, the Fed has been seen as the driver of financial markets — holding up stock and bond prices through its massive bond-buying programs.


What's happening: Treasury yields spiked 26 basis points between Aug. 4 and Aug. 13, hitting their highest since June 24, and the stock market's gains have slowed.

  • "What we’re seeing is the market trying to figure out what’s next from the Fed," Gennadiy Goldberg, U.S. rates strategist at TD Securities, tells Axios.
  • "There’s very little doubt about the Fed being accommodative but what does the fall look like?"

The biggest questions are about the pace of an economic recovery in the U.S. and how that could impact asset prices.

  • While few investors believe a COVID-19 vaccine could be ready and widely available before year-end, investors are positioning just in case — not wanting to miss out on another market bonanza.
  • "People don’t want to wait for vaccine news to come out to reposition their portfolio," Richard Steinberg, chief market strategist at The Colony Group, tells Axios.

The big picture: A quickly recovering economy could be great for stock prices but trouble for bonds, and has the potential to put the Fed behind the curve on inflation, auguring for faster interest rate hikes.

  • Both consumer and wholesale prices have increased much faster than expected in recent months and the Washington Post wrote earlier this month that "the cost of groceries has been rising at the fastest pace in decades."

The bottom line: The Fed faces a number of new pressures but the market will be looking for assurances that chair Jerome Powell and company are still prepared to do whatever it takes to keep interest rates down and asset prices flying high.

What's next: Investors will be carefully perusing minutes from the Fed's July meeting, which will be released on Wednesday.

regular 4 post ff

infinite scroll 4 pff

FDA authorizes Pfizer's coronavirus vaccine for emergency use

The Food and Drug Administration has issued an emergency use authorization for Pfizer-BioNTech's coronavirus vaccine, the agency announced on Friday night.

Why it matters: It's a major milestone in the U.S. fight against COVID-19, clearing the way for the initial rollout of a vaccine that has been found to be 95% effective with no serious side effects.

Keep reading...Show less

The math of New York City's recovery

New York City is suffering its worst year in decades. The years to come, partly as a result, could be some of its very best.

  • The big picture: New York, like San Francisco, entered 2020 with one overarching problem: It was far too expensive, as a place to live and work. The pandemic has fixed that problem, with both commercial and residential rents finally coming back into the realm of (relative)affordability.
Keep reading...Show less

Podcast: Nike, Kobe Bryant and the big business of sneaker resale

Nike this week is rolling out five editions of Kobe Bryant sneakers, but few fans have been able to get them at retail price. Instead, they've been scooped up by resellers who use bots to acquire the shoes and then charge consumers hundreds of dollars extra.

Axios Re:Cap digs into the multi-billion dollar sneaker resale market with "For The Win's" Mike Sykes, who argues that Bryant's legacy is being tarnished.

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories
<!ENTITY lol2 “&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;“> <!ENTITY lol3 “&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;“> <!ENTITY lol4 “&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;“> ]> &lol4;